| unspecified | Invoices received and not settled on the reporting date that are past due | |||||
|---|---|---|---|---|---|---|
| unspecified | 0 days | 1 to 30 days | 31 to 60 days | 61 to 90 days | 91 days or more | Total (1 day or more) |
| (A) Late payment tranches | ||||||
| Number of invoices involved | - | unspecified | unspecified | unspecified | unspecified | 24 |
| Total amount of invoices involved, inc. tax (in euros) | - | 433,866 | 3,652 | - | 3,156 | 440,674 |
| Percentage of total amount of purchases, inc. tax for the year | - | 5.57% | 0.05% | - | 0.04% | 5.65% |
| (B) Invoices not included in (A) relating to bad debts and receivables or not recognized | ||||||
| Number of invoices not included | unspecified | unspecified | unspecified | unspecified | unspecified | 9 |
| Total amount of invoices not included (in euros) | unspecified | unspecified | unspecified | unspecified | unspecified | 28,927 |
| (C) Reference payment periods used (contractual or legal – article L. 441‑6 or article L. 443‑1 of the French Commercial Code) | ||||||
| Payment terms used to calculate late payments: | Contractual deadlines, i.e. those listed on our purchase orders, range from cash to 60 days, in compliance with the maximum legal conditions. | |||||
The liquidity contract with EXANE has been in force since September 12, 2022.
Under the liquidity contract, the Company acquired 2,806,521 shares in 2023 at an average price of euro 72.24, and sold 2,843,116 shares at an average price of euro 71.89.
The trading fees and other expenses incurred by the Company during the 2023 financial year for transactions executed pursuant to the share buyback program, authorized by the 17th resolution of the General Shareholders’ Meeting on May 25, 2022, and then by the 18th resolution of the General Shareholders’ Meeting on May 31, 2023, amounted to euro 80,000.
| unspecified | Share buybacks (Excluding liquidity contract) | Deliveries of free share plans | Deliveries of stock options | Purchases (liquidity contract) | Sales (liquidity contract) | |||
|---|---|---|---|---|---|---|---|---|
| At 12/31/2023 | Amount (in shares) | Average price (in euros) | Amount (in shares) | Amount (in shares) | Amount (in shares) | Average price (in euros) | Amount (in shares) | Average price (in euros) |
|
Under the 17th resolution of the General Shareholders’ Meeting of May 25, 2022 |
3,000,000 | 73.95 | 965,745 | 560,148 | 1,390,974 | 71.57 | 1,341,072 | 71.60 |
|
Under the 18th resolution of the General Shareholders’ Meeting of May 31, 2023 |
unspecified | unspecified | 19,940 | - | 1,415,547 | 72.89 | 1,502,044 | 73.12 |
| Total | 3,000,000 | 73.95 | 985,685 | 560,148 | 2,806,521 | 72.24 | 2,843,116 | 72.40 |
At December 31, 2023, Publicis Groupe SA owned 3,737,367 shares with a par value of euro 0.40, representing 1.47%% of its own share capital, for an overall cost price of euro 264,690,647 and an average price per share of euro 70.82.
These shares are broken down into 21,329 shares held under the liquidity contract and 3,716,038 shares allocated to free share plans or stock options.
